Author/Authors :
Ishii، نويسنده , , Kazuyoshi and Urase، نويسنده , , Fumiaki and Nagare، نويسنده , , Yasuaki and Kimura، نويسنده , , Hidetsugu and Manabe، نويسنده , , Masahiro and Yagi، نويسنده , , Toshiya and Teshima، نويسنده , , Hirofumi and Hayashi، نويسنده , , Kunio and Shibano، نويسنده , , Masaru and Tsukaguchi، نويسنده , , Machiko and Katsurada، نويسنده , , Tatsuya and Mugitani، نويسنده , , Atsuko and Kitay، نويسنده ,
Abstract :
CHOP (cyclophosphamide, adriamycin, vincristine, and prednisolone) plus rituximab is a standard chemotherapy used to treat patients with aggressive B-cell non-Hodgkin lymphoma (B-NHL). However, among elderly patients, this regimen has not been completely
Keywords :
Aggressive B-cell non-Hodgkin lymphoma , Treatment of B-cell non-Hodgkin lymphoma in elderly , VNCOP-B plus rituximab , IgG
